2320 Druid Hl Rd Brookhaven, GA 30329
This exceptional investment opportunity presents a freestanding Walgreens pharmacy in Brookhaven, GA, a thriving affluent area just nine miles from downtown Atlanta. The property boasts a 10,453 square foot building on a 1.08-acre lot, constructed in 2010. Currently operating under a triple-net (NNN) lease with Walgreens, a corporate guarantor, the lease extends until March 31, 2035, offering a substantial remaining term of 10.4 years. The property enjoys a strong financial performance, generating a net operating income (NOI) of $565,000, representing an 8.00% cap rate and a price per square foot of $676.36. The asking price is $7,070,000. The location is highly desirable, situated on a busy corner with 50,000 cars passing daily, and benefits from a densely populated area with an average household income exceeding $146,070. The lease includes a preferred 10-year term with 5-year renewal options, minimizing landlord responsibilities. This single-tenant, fee-simple ownership offers a secure and lucrative investment opportunity in a prime Atlanta location, surrounded by complementary businesses including Target, DoubleTree by Hilton, and various restaurants. The property's strong tenant, high traffic count, and long-term lease make it an attractive addition to any investment portfolio.
-
Walgreens Pharmacy
-
Walgreens Pharmacy Pharmacy
-
Walgreens Photo (Bike/Boat/Book/etc) Store
-
Evelyn Henry, RPH Pharmacy
-
COVID-19 Drive-Thru Testing at Walgreens Pharmacy
Cap rate
Implied · in-place · derived from last sale + estimated NOIValue
AI, CAP & Alternative Use estimations · Realmo proprietary blendComparables
6 recent transactions · within 1.5 miComparable in this City
Similar Nearby for Sale
Similar Nearby for Lease
Property description
Physical attributes from public recordsZoning & alternative use
No recorded transactions found for this property.
Costs & Benchmarks
Operating expenses, capex projections, utility benchmarks, and submarket comparables — all in one view.
Risks
Flood, climate, environmental, title, and tenant-concentration risk — surfaced with mitigations and source citations.